Diabetes advocacy group discourages use of compounded GLP 1 drugs BioPharma Dive The FDA just approved semaglutide (specifically under the brand Wegovy who submitted the research for approval), for the treatment of Non Alcoholic Fatty Liver Disease, specifically Metabolic associated steatohepatitis (MASH). In combination Weight loss injections like Mounjaro and Ozempic are changing lives but there's a side effect not enough people are talking about. Rapid weight loss is a well recognised trigger for gallstone disease, and in Ozempic Face: Combat with Protein Secrets